'Ketamine Queen' Takes Plea Deal In Matthew Perry Case

By Hailey Konnath

The woman known as the "Ketamine Queen" of North Hollywood has agreed to plead guilty to providing the ketamine that led to the 2023 death of "Friends" star Matthew Perry, according to a plea agreement filed in California federal court on Monday.

1 document attached | Read full article » | Save to favorites »

Boehringer Long Ignored Zantac's Cancer Risks, Jury Hears

By Lauraann Wood

Boehringer Ingelheim ignored years of mounting concerns that the active ingredient in its over-the-counter drug Zantac degraded into a highly toxic compound, and it simply changed the color of its tablets to shield their problems, a colorectal cancer patient told an Illinois state jury Monday.

Read full article » | Save to favorites »

Most Ozempic, Wegovy Claims Survive MDL Dismissal Bid

By Matthew Santoni

Eli Lilly & Co. and Novo Nordisk will have to face most of a multidistrict litigation accusing them of misleading consumers over the risks and benefits of popular weight loss drugs like Ozempic and Trulicity, after a Pennsylvania federal judge only trimmed a few of the dozen claims the drugmakers tried to have tossed.

Memorandum attached | Read full article » | Save to favorites »

HHS Says Layoffs, Reorganization Are Within Its Authority

By Lauren Berg

The Trump administration urged a Rhode Island federal judge to toss claims that massive cuts to the Health and Human Services Department violate the U.S. Constitution and usurp congressional authority, arguing the state plaintiffs don't have the authority to dictate how the executive branch manages its personnel.

Motion attached | Read full article » | Save to favorites »

DEA Asks Health Officials To Review Psilocybin Rescheduling

By Sam Reisman

The U.S. Drug Enforcement Administration has transmitted a request to loosen federal restrictions on psilocybin, the main compound in psychoactive mushrooms, to federal health officials for a scientific and medical analysis, according to emails reviewed by Law360.

Read full article » | Save to favorites »

Pharma Company Beats Investor Suit Over Drug Safety Claims

By Sydney Price

ChemoCentryx, a California-based pharmaceutical company, has secured summary judgment in shareholder litigation accusing it of overstating the efficacy of its newly developed treatment for an autoimmune disease called ANCA vasculitis, with a California court ruling that the ultimate regulatory approval of the drug may show that the company was not intentionally overhyping it.

Order attached | Read full article » | Save to favorites »

Akero Investor Suit Over Liver Drug Trials Permanently Tossed

By Gina Kim

A California federal judge has permanently ended Akero Therapeutics investors' proposed class action alleging they were misled about the patient population in the company's liver disease treatment clinical trial, ruling the investors did not "fill-in the logical gaps" she previously identified when dismissing their earlier pleading for failing to plead scienter. 

Order attached | Read full article » | Save to favorites »

Life Sciences Data Rivals Settle Trade Secrets Battle

By Elliot Weld

Life sciences data company IQVIA Inc. has settled a suit that alleged data rival Veeva Systems Inc. used "crowdsourcing" to misappropriate trade secrets, the two companies said Monday.

1 document attached | Read full article » | Save to favorites »

LabMD Fights Dinsmore's Bid To Toss Malpractice Suit

By Rose Krebs

Now-shuttered LabMD Inc. and its CEO are pushing back against a bid from Dinsmore & Shohl LLP and a legal nonprofit to have a malpractice suit in Georgia federal court tossed, saying they haven't abandoned the case but rather were delayed in pursuing arbitration because they were searching for "competent counsel."

Brief attached | Read full article » | Save to favorites »

Catching Up With Delaware's Chancery Court

By Sydney Price and Jeff Montgomery

Executives and board members of Cencora Corp. tentatively settled a stockholder derivative suit for $111.25 million, VectoIQ board members reached a $6.3 million deal on stockholder claims over electric carmaker Nikola's prospects, and class attorneys who secured a $50 million derivative suit settlement saw their proposed 25% attorney fee cut by almost half. Here's the latest from the Delaware Chancery Court.

Read full article » | Save to favorites »

What Patent Claim 'Invalidity' Means In Different Forums

A recent Federal Circuit order allowing a patent suit to proceed despite similar claims being invalidated in an inter partes review underscores how fractured the patent litigation landscape has become, leading to critical nuances in how district courts, the U.S. International Trade Commission and Patent Trial and Appeal Board treat invalidity, says Jason Hoffman at BakerHostetler.

Order attached | Read full article » | Save to favorites »

Rebuttal

BigLaw Settlements Should Not Spur Ethics Deregulation

A recent Law360 op-ed argued that loosening law firm funding restrictions would make BigLaw firms less inclined to settle with the Trump administration, but deregulating legal financing ethics may well prove to be not merely ineffective, but counterproductive, says Laurel Kilgour at the American Economic Liberties Project.

Read full article » | Save to favorites »

Litigation Funder Burford Eyes Investments In US Law Firms

By Ryan Boysen

Burford Capital LLC, the world's largest litigation funder, is eyeing an investment model to put money directly in U.S. law firms after years of investing in U.S. lawsuits, its chief development officer told Law360 Pulse.

Read full article » | Save to favorites »

Fired DOJ Antitrust Deputy Warns Of Lobbyist Influence

By Matthew Perlman

The former top deputy for the U.S. Department of Justice Antitrust Division, Roger P. Alford, defended the agency's leadership Monday while calling out a pair of senior officials and warning of the influence that lobbyists are wielding over merger reviews and other issues.

Read full article » | Save to favorites »

Fried Frank Escapes Sanctions Over Flawed RICO Patent Suit

By Emily Sawicki

A Florida federal court has rejected sanctions motions leveled against Tristar Products Inc. and its counsel at Fried Frank for bringing a doomed anti-racketeering patent fraud lawsuit against Telebrands Corp., finding that the claims were not frivolous despite "myriad" flaws and "sloppy lawyering."

Order attached | Read full article » | Save to favorites »

SDNY Judges OK Trump's Selection Of Jay Clayton As US Atty

By Hailey Konnath

The Southern District of New York on Monday permitted Jay Clayton to continue overseeing the district's prosecutorial office, appointing Clayton as U.S. attorney just a day before his tenure as interim U.S. attorney was set to expire.

1 document attached | Read full article » | Save to favorites »

Burr & Forman Must Face Claims From Healthcare Scheme

By Chart Riggall

A Georgia federal judge has denied Burr & Forman LLP's bid to escape a lawsuit accusing the firm of being party to a massive healthcare fraud scheme, ruling that it must largely face malpractice and breach of fiduciary claims from a pair of bankruptcy trustees.

Order attached | Read full article » | Save to favorites »

NJ Feds Say Habba's US Atty Role Unusual, But Not Unlawful

By Lauren Berg

Acting U.S. Attorney Alina Habba on Monday doubled down on her argument that President Donald Trump legally appointed her New Jersey's top federal prosecutor, telling a federal judge that this is simply "an unusual situation" created when the district court last month refused to extend her interim tenure.

Brief attached | Read full article » | Save to favorites »

Lawmaker Pans 'Selective' Charges Over ICE Facility Clash

By Carla Baranauckas

U.S. Rep. LaMonica McIver has moved to dismiss criminal charges against her from a May confrontation with federal agents at an immigrant detention center in Newark, New Jersey, arguing she is immune from prosecution under the U.S. Constitution's speech or debate clause and is being selectively targeted by the government.

4 documents attached | Read full article » | Save to favorites »

Ex-NY AG Immune From Malicious Prosecution Suit

By Cara Salvatore

Former New York Attorney General Eric Schneiderman has immunity from a suit by a former New York City Council member claiming wrongful prosecution, a federal judge has ruled.

Order attached | Read full article » | Save to favorites »

Whiteford Taylor Must Face Wire Fraud Malpractice Suit

By Emily Sawicki

A Maryland federal judge has declined to toss the majority of a malpractice and gross negligence suit brought by the founder of a construction company who accused his former business partners and their shared counsel of being partially to blame for hackers stealing his $4 million share of proceeds from the sale of their business.

Opinion attached | Read full article » | Save to favorites »

Treasury Seeks Input On Tech To Combat Crypto Crimes

By Aislinn Keely

The U.S. Department of the Treasury on Monday asked the public to share feedback on how novel technologies might be used to detect and thwart illicit crypto activity, fulfilling a directive under a recently signed bill to regulate stable value tokens.

Notice attached | Read full article » | Save to favorites »